Skip to main content

Phibro Animal Health Corporation (PAHC) Stock

Phibro Animal Health Corporation Stock Details, Movements and Public Alerts

Stock Details

Phibro Animal Health Corporation (PAHC), a prominent company in the healthcare sector within the drug manufacturers - specialty & generic industry, is based in USA and primarily trades on the NASDAQ.Currently, the stock is trading at $55.66. Over the past 52 weeks, it has ranged between $15.95 and $57.62. This places the current price at 96.6% of its 52-week high and 249.0% above its 52-week low. Recent trading volume was recorded at 233,957. The 14-day Relative Strength Index (RSI) stands at 68.15, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $48.16 by 15.57%. Similarly, it is above its 200-day moving average of $38.67 by 43.94%. The MACD histogram is 0.35, indicating bullish momentum (MACD Line: 1.57, Signal Line: 1.22). There is currently 1 active alert set for PAHC by users.

52-Week Range

$57.62 - $15.95

-3.40% from high · +248.97% from low

Avg Daily Volume

301,791

20-day average

100-day avg: 290,999

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

24.57

Near market average

Forward P/E

10.57

Earnings expected to grow

PEG Ratio

1.66

Reasonably valued

Price to Book

6.68

EV/EBITDA

13.47

EPS (TTM)

$2.26

Price to Sales

1.54

Beta

0.69

Less volatile than market

Q:How is PAHC valued relative to its earnings and growth?
Phibro Animal Health Corporation trades at a P/E ratio of 24.57, which is near the market average of approximately 20, suggesting the market views it as fairly valued relative to its earnings. Looking ahead, the forward P/E of 10.57 is lower than the current P/E, indicating analysts expect earnings to grow over the next year. The PEG ratio of 1.66 indicates reasonable value when growth is considered.
Q:What is PAHC's risk profile compared to the market?
With a beta of 0.69, Phibro Animal Health Corporation is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability. The price-to-book ratio of 6.68 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

6.29%

Operating Margin

14.70%

EBITDA

$228.84M

Return on Equity

31.80%

Return on Assets

8.34%

Revenue Growth (YoY)

20.90%

Earnings Growth (YoY)

752.00%

Q:How profitable and efficient is PAHC's business model?
Phibro Animal Health Corporation achieves a profit margin of 6.29%, meaning it retains $6.29 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 14.70% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 31.80% and ROA at 8.34%, the company generates strong returns on invested capital.
Q:What are PAHC's recent growth trends?
Phibro Animal Health Corporation's revenue grew by 20.90% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. Earnings increased by 752.00% year-over-year, outpacing revenue growth through improved margins. These growth metrics should be evaluated against DRUG MANUFACTURERS - SPECIALTY & GENERIC industry averages for proper context.

Dividend Information

Dividend Per Share

$0.48

Dividend Yield

0.88%

Ex-Dividend Date

Mar 4, 2026

Dividend Date

Mar 25, 2026

Q:What dividend income can investors expect from PAHC?
Phibro Animal Health Corporation offers a dividend yield of 0.88%, paying $0.48 per share annually. This modest yield below 2% suggests the company prioritizes growth investments over current income. While the dividend provides some return, investors are likely attracted more by capital appreciation potential than income generation. To receive the next dividend, shares must be purchased before the ex-dividend date of Mar 4, 2026.
Q:How reliable is PAHC's dividend for long-term investors?
The dividend sustainability can be assessed through the payout ratio - Phibro Animal Health Corporation pays $0.48 per share in dividends against earnings of $2.26 per share, resulting in a payout ratio of 21.24%. This conservative payout below 30% indicates excellent dividend safety with substantial room for future increases. The company retains most earnings for growth while still rewarding shareholders. The next dividend payment is scheduled for Mar 25, 2026.

Company Size & Market

Market Cap

$2.3B

Revenue (TTM)

$1.46B

Revenue/Share (TTM)

$36.13

Shares Outstanding

20.62M

Book Value/Share

$8.20

Asset Type

Common Stock

Q:What is PAHC's market capitalization and position?
Phibro Animal Health Corporation has a market capitalization of $2.3B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 20.62M shares outstanding, the company's ownership is relatively concentrated. As a participant in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry, it competes with other firms in this sector.
Q:How does PAHC's price compare to its book value?
Phibro Animal Health Corporation's book value per share is $8.20, while the current stock price is $55.66, resulting in a price-to-book (P/B) ratio of 6.79. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As a common stock, this represents equity ownership with voting rights.

Analyst Ratings

Analyst Target Price

$48.50

12.86% downside potential

Analyst Recommendations

No analyst ratings available

Q:How reliable are analyst predictions for PAHC?
0 analysts cover PAHC with 0% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $48.50 implies -12.9% downside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on PAHC?
Current analyst recommendations:The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Apr 5, 2026, 02:49 AM

Technical Indicators

RSI (14-day)

68.15

Neutral

50-Day Moving Average

$48.16

15.57% above MA-50

200-Day Moving Average

$38.67

43.94% above MA-200

MACD Line

1.57

MACD Signal

1.22

MACD Histogram

0.35

Bullish

Q:What does PAHC's RSI value tell investors?
The RSI (Relative Strength Index) for PAHC is currently 68.15, indicating the stock is showing bullish momentum (60-70 range). The stock has positive momentum without being extremely overbought. This zone often occurs during healthy uptrends where buyers remain in control. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret PAHC's MACD and moving average crossovers?
MACD analysis shows the MACD line at 1.57 above the signal line at 1.22, with histogram at 0.35. This bullish crossover suggests upward momentum is building. The 50-day MA ($48.16) is above the 200-day MA ($38.67), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Mar 26, 2026, 03:16 AM

Active Alerts

Alert Condition
Price falls below
Threshold
$53.01
Created
Mar 26, 2026, 03:16 AM

Stay Ahead of the Market with Phibro Animal Health Corporation Alerts

Set up price alerts for Phibro Animal Health Corporation and get notified instantly when the price hits your target. Never miss an important price movement again.